--A-Mark Precious Metals Keeps Quarterly Cash Dividend at $0.20 per Share, Payable Jan. 28 to Holders as of Jan. 14-March 2024-www.financetom.com

--A-Mark Precious Metals Keeps Quarterly Cash Dividend at $0.20 per Share, Payable Jan. 28 to Holders as of Jan. 14

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

--A-Mark Precious Metals Keeps Quarterly Cash Dividend at $0.20 per Share, Payable Jan. 28 to Holders as of Jan. 14

Jan 3, 2025 7:33 AM

10:08 AM EST, 01/03/2025 (MT Newswires) --

Price: 27.61, Change: -0.18, Percent Change: -0.63

Previous page： Private equity 'secondary' sales hit record as Ardian closes $30 bln fund Next page： Correction: TD Bank Brief: Chun previously slated To Take Over As CEO On April 10, 2025

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Private equity 'secondary' sales hit record as Ardian closes $30 bln fund

Jan 17, 2025

* Private equity secondary market booming * Continuation funds up around four-fold in five years * PE funds try to 'hold on to best assets for longer' * Discounts are narrowing, eating into returns By Mathieu Rosemain and Andres Gonzalez PARIS/LONDON, Jan 17 - The secondary market for private equity funds saw record transaction volumes last year as buyout bosses...

Correction: TD Bank Brief: Chun previously slated To Take Over As CEO On April 10, 2025

Jan 17, 2025

08:26 AM EST, 01/17/2025 (MT Newswires) -- (In a prior headline Raymond Chun's surname was written twice. A corrected headline follows.) ...

Puma Exploration Completes Agreements for McKenzie Gold Project

Jan 17, 2025

08:24 AM EST, 01/17/2025 (MT Newswires) -- Puma Exploration ( PUMXF ) on Friday completed its transactions with NB Gold and Comet Lithium ( XTRRF ) on Jan. 16 for the McKenzie Gold Project. The company said it issued the remaining 200,000 shares to NB Gold to complete the TIMM Property Option, made a cash payment of $20,000 and issued...

Astrazeneca Says Mantle Cell Lymphoma Combination Treatment Receives FDA Approval

Jan 17, 2025

08:26 AM EST, 01/17/2025 (MT Newswires) -- AstraZeneca ( AZN ) said Friday that the US Food and Drug Administration has approved its experimental drug, calquence, combined with bendamustine and rituximab, for the treatment of certain adult patients with previously untreated mantle cell lymphoma. The company said the approval was based on phase III results that showed calquence plus bendamustine...